XML 23 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Aug. 31, 2018
Aug. 31, 2017
Aug. 31, 2016
Cash flows from operating activities:      
Net income (loss) $ 159,789 $ 46,978 $ (17,588)
Adjustments to reconcile net income (loss) to cash provided by operating activities:      
Goodwill impairment charges 0 0 8,845
Other asset impairment charges (recoveries), net (1,021) (717) 20,682
Exit-related (gains), asset impairments and accelerated depreciation, net (1,000) (407) 1,790
Depreciation and amortization 49,672 49,840 54,630
Inventory write-downs 38 0 710
Deferred income taxes (37,995) 2,278 507
Undistributed equity in earnings of joint ventures (1,953) (3,674) (819)
Share-based compensation expense 18,965 10,847 10,437
Loss (gain) on the disposal of assets, net 56 448 (465)
Unrealized foreign exchange (gain) loss, net (104) 361 (109)
Bad debt expense, net 323 126 131
Write-off of debt issuance costs 0 0 768
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable (44,941) (36,195) (10,693)
Inventories (24,280) (22,207) 27,504
Income taxes (1,755) (1,086) 5,861
Prepaid expenses and other current assets (109) (1,704) (1,864)
Other long-term assets (1,620) 537 266
Accounts payable 26,049 33,062 (763)
Accrued payroll and related liabilities 4,889 12,389 3,633
Other accrued liabilities 6,066 5,073 (4,362)
Environmental liabilities 3,053 1,884 (451)
Other long-term liabilities 4,404 (1,101) 30
Distributed equity in earnings of joint ventures 1,150 3,638 560
Net cash provided by operating activities 159,676 100,370 99,240
Cash flows from investing activities:      
Capital expenditures (77,626) (44,940) (34,571)
Purchase of cost method investment 0 (6,017) 0
Acquisition (2,300) 0 0
Joint venture receipts (payments), net 11 405 (11)
Proceeds from sale of assets 6,517 5,158 4,106
Net cash used in investing activities (73,398) (45,394) (30,476)
Cash flows from financing activities:      
Borrowings from long-term debt 515,480 433,336 152,311
Repayment of long-term debt (556,456) (481,757) (187,951)
Proceeds from line of credit 0 0 135,500
Repayment of line of credit 0 0 (135,500)
Payment of debt issuance costs (2,590) (112) (1,011)
Repurchase of Class A common stock (17,361) 0 (3,479)
Taxes paid related to net share settlement of share-based payment awards (3,082) (3,474) (2,213)
Distributions to noncontrolling interests (2,796) (2,271) (2,126)
Purchase of noncontrolling interest (600) 0 0
Dividends paid (20,736) (20,396) (20,444)
Net cash used in financing activities (88,141) (74,674) (64,913)
Effect of exchange rate changes on cash (701) 166 213
Net increase (decrease) in cash and cash equivalents (2,564) (19,532) 4,064
Cash and cash equivalents as of beginning of year 7,287 26,819 22,755
Cash and cash equivalents as of end of year 4,723 7,287 26,819
Cash paid (received) during the year for:      
Interest 8,113 7,016 6,077
Income taxes paid (refunds received), net 17,203 148 (5,691)
Schedule of noncash investing and financing transactions:      
Purchases of property, plant and equipment included in current liabilities $ 18,768 $ 11,082 $ 8,268